UNSPSC 41141907: 6-phosphogluconate dehydrogenase test system

In this classification, 6-phosphogluconate dehydrogenase test system connotes a device used to measure 6-phosphogluconate dehydrogenase levels. US FDA regulates 6-phosphogluconate dehydrogenase test system under 21 CFR 862.1565 and under FDA product code JND.

UNSPSC 41141907 6-phosphogluconate dehydrogenase test system (Commodity) covers diagnostic and forensic laboratory reagent kits and certified reference materials that state and local governments procure for substance analysis, toxicology screening, and method validation in crime labs and public health laboratories. State and local buyers under this code include state crime and forensic laboratories, state health departments, county forensic labs, and specialized testing divisions operating within law enforcement or health agency structures. The work solicited ranges from immunoanalysis reagent kits for screening controlled substances (cannabinoids, opiates, amphetamines, benzodiazepines, oxycodone, cocaine, and others) to certified drug reference standards meeting ISO/IEC 17025 accreditation and purity thresholds above 97%, all supporting forensic drug analysis, evidence validation, and laboratory quality assurance operations.

Texas and Florida account for the most recent solicitation activity under this code. The Texas Department of Public Safety Crime Lab Division issued IFB 405-26R0008445A (posted July 9, 2026, due July 23, 2026) requesting Direct ELISA testing kits across 12 line items for substance analysis and phosphate-buffered saline solution, with quantities ranging from 3 to 30 units per line item and an anticipated award on July 24, 2026. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, solicited certified reference materials (drug standards) through ITQ 26-0305-ITQ (posted April 23, 2026, due April 23, 2026) for 131 line items spanning specific drug standards with ISO/IEC 17025 accreditation compliance and purity exceeding 97%, funded through the Paul Coverdell Forensic Sciences Improvement Act Program with $72,126.85 in federal support ($49,034.00 allocated to equipment and supplies including drug standards). The Texas Health and Human Services Commission also procured DNA screening and QIAxcel kits through IFB HHS0016902v2 (due January 29, 2026) with historical values between $25,050.00 and $30,000.00 in fiscal year 2025. Recent opportunities show state procurement offices and county forensic labs treating this code as a core recurring need tied to forensic and public health laboratory operations.